A study shows that proton pump inhibitor therapy for 8 weeks induced acid-related symptoms in healthy volunteers after withdrawal, suggesting that rebound acid hypersecretion has clinical implications. Medscape Medical News
Telaprevir added to standard therapy for chronic hepatitis C virus (HCV) was an improvement over the usual interferon/ribavirin protocol in a recent study in Japan. Reuters Health Information
Might a minimally invasive combination therapy of ERCP and ESWL avoid major pancreatic surgery in the majority of patients with pancreatic duct stones? Southern Medical Journal
Do HCV-RNA positive patients with recent diagnosis of their HCV infection who have not yet undergone antiviral therapy display significantly different QOL scores? Journal of Viral Hepatitis
The FDA has approved revisions to safety labeling for conjugated estrogens plus medroxyprogesterone acetate tablets, conjugated estrogens injection, and octreotide acetate for injectable suspension. Medscape Medical News
